Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9532)	4/5/1999 8:35:00 AM
From: xomadog2	Respond to of 17367

Although I have nothing to base my thought on except a blurb here or there that I have read, I believe that the reduced level of mortality in the trial might be connected to the age of the patients being enrolled. I remember reading somewhere along the way,that children have a lower mortality rate than adults.Maybe the age of the accrued children patients,are older rather than younger in age.12-14 instead of 1-5. I concur with Robert K. re production of BPI. ALL standard disclaimers etc. dont rely on anything I post etc.